UniProt ID | RFX3_HUMAN | |
---|---|---|
UniProt AC | P48380 | |
Protein Name | Transcription factor RFX3 | |
Gene Name | RFX3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 749 | |
Subcellular Localization | Nucleus . | |
Protein Description | Transcription factor required for ciliogenesis and islet cell differentiation during endocrine pancreas development. Essential for the differentiation of nodal monocilia and left-right asymmetry specification during embryogenesis. Required for the biogenesis of motile cilia by governing growth and beating efficiency of motile cells. Also required for ciliated ependymal cell differentiation. Regulates the expression of genes involved in ciliary assembly (DYNC2LI1, FOXJ1 and BBS4) and genes involved in ciliary motility (DNAH11, DNAH9 and DNAH5) (By similarity). Together with RFX6, participates in the differentiation of 4 of the 5 islet cell types during endocrine pancreas development, with the exception of pancreatic PP (polypeptide-producing) cells. Regulates transcription by forming a heterodimer with another RFX protein and binding to the X-box in the promoter of target genes. [PubMed: 20148032 Represses transcription of MAP1A in non-neuronal cells but not in neuronal cells] | |
Protein Sequence | MQTSETGSDTGSTVTLQTSVASQAAVPTQVVQQVPVQQQVQQVQTVQQVQHVYPAQVQYVEGSDTVYTNGAIRTTTYPYTETQMYSQNTGGNYFDTQGSSAQVTTVVSSHSMVGTGGIQMGVTGGQLISSSGGTYLIGNSMENSGHSVTHTTRASPATIEMAIETLQKSDGLSTHRSSLLNSHLQWLLDNYETAEGVSLPRSTLYNHYLRHCQEHKLDPVNAASFGKLIRSIFMGLRTRRLGTRGNSKYHYYGIRVKPDSPLNRLQEDMQYMAMRQQPMQQKQRYKPMQKVDGVADGFTGSGQQTGTSVEQTVIAQSQHHQQFLDASRALPEFGEVEISSLPDGTTFEDIKSLQSLYREHCEAILDVVVNLQFSLIEKLWQTFWRYSPSTPTDGTTITESSNLSEIESRLPKAKLITLCKHESILKWMCNCDHGMYQALVEILIPDVLRPIPSALTQAIRNFAKSLEGWLSNAMNNIPQRMIQTKVAAVSAFAQTLRRYTSLNHLAQAARAVLQNTSQINQMLSDLNRVDFANVQEQASWVCQCDDNMVQRLETDFKMTLQQQSTLEQWAAWLDNVMMQALKPYEGRPSFPKAARQFLLKWSFYSSMVIRDLTLRSAASFGSFHLIRLLYDEYMFYLVEHRVAQATGETPIAVMGEFGDLNAVSPGNLDKDEGSEVESEMDEELDDSSEPQAKREKTELSQAFPVGCMQPVLETGVQPSLLNPIHSEHIVTSTQTIRQCSATGNTYTAV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
155 | Phosphorylation | VTHTTRASPATIEMA CCCCCCCCHHHHHHH | 16.27 | 29255136 | |
158 | Phosphorylation | TTRASPATIEMAIET CCCCCHHHHHHHHHH | 22.36 | 29255136 | |
165 | Phosphorylation | TIEMAIETLQKSDGL HHHHHHHHHHHCCCC | 28.51 | 23403867 | |
169 | Phosphorylation | AIETLQKSDGLSTHR HHHHHHHCCCCCHHH | 24.77 | 24719451 | |
173 | Phosphorylation | LQKSDGLSTHRSSLL HHHCCCCCHHHHHHH | 27.91 | 30108239 | |
174 | Phosphorylation | QKSDGLSTHRSSLLN HHCCCCCHHHHHHHH | 26.76 | 30108239 | |
198 | Phosphorylation | YETAEGVSLPRSTLY CCCCCCCCCCHHHHH | 43.44 | 24719451 | |
227 | Ubiquitination | VNAASFGKLIRSIFM CCHHHHHHHHHHHHH | 38.44 | - | |
257 | Ubiquitination | HYYGIRVKPDSPLNR EEEEEEECCCCHHHH | 33.00 | 29967540 | |
260 | Phosphorylation | GIRVKPDSPLNRLQE EEEECCCCHHHHHHH | 39.55 | 25159151 | |
374 | Phosphorylation | VVVNLQFSLIEKLWQ HHHHHHHHHHHHHHH | 18.57 | 24719451 | |
382 | Phosphorylation | LIEKLWQTFWRYSPS HHHHHHHHHHHCCCC | 17.37 | 22468782 | |
395 | Phosphorylation | PSTPTDGTTITESSN CCCCCCCCEEECCCC | 20.17 | - | |
398 | Phosphorylation | PTDGTTITESSNLSE CCCCCEEECCCCHHH | 27.94 | - | |
400 | Phosphorylation | DGTTITESSNLSEIE CCCEEECCCCHHHHH | 18.84 | 22468782 | |
401 | Phosphorylation | GTTITESSNLSEIES CCEEECCCCHHHHHH | 35.24 | 22468782 | |
423 | Phosphorylation | ITLCKHESILKWMCN HHHCCCHHHHHHHHC | 32.70 | 24719451 | |
490 | Phosphorylation | QTKVAAVSAFAQTLR HHHHHHHHHHHHHHH | 16.97 | 24670416 | |
499 | Phosphorylation | FAQTLRRYTSLNHLA HHHHHHHHHCHHHHH | 8.34 | 23312004 | |
500 | Phosphorylation | AQTLRRYTSLNHLAQ HHHHHHHHCHHHHHH | 25.56 | 23312004 | |
501 | Phosphorylation | QTLRRYTSLNHLAQA HHHHHHHCHHHHHHH | 20.45 | 23312004 | |
542 | S-palmitoylation | QEQASWVCQCDDNMV HHHHHEEEECCHHHH | 2.44 | 30127002 | |
544 | S-palmitoylation | QASWVCQCDDNMVQR HHHEEEECCHHHHHH | 6.33 | 30127002 | |
616 | Phosphorylation | IRDLTLRSAASFGSF HHHHHHHHHHHCCCH | 31.16 | 28122231 | |
619 | Phosphorylation | LTLRSAASFGSFHLI HHHHHHHHCCCHHHH | 29.83 | 28122231 | |
649 | Phosphorylation | VAQATGETPIAVMGE HHHHHCCCCEEEEEE | 22.72 | 27080861 | |
664 | Phosphorylation | FGDLNAVSPGNLDKD CCCCCCCCCCCCCCC | 25.36 | 25849741 | |
674 | Phosphorylation | NLDKDEGSEVESEMD CCCCCCCCCHHHHCC | 36.10 | 27499020 | |
678 | Phosphorylation | DEGSEVESEMDEELD CCCCCHHHHCCHHCC | 43.31 | 27499020 | |
687 | Phosphorylation | MDEELDDSSEPQAKR CCHHCCCCCCCHHHH | 35.95 | 21406692 | |
688 | Phosphorylation | DEELDDSSEPQAKRE CHHCCCCCCCHHHHH | 61.36 | 21406692 | |
739 | S-palmitoylation | STQTIRQCSATGNTY CCCHHHHHCCCCCCE | 1.83 | 30127002 | |
742 | Phosphorylation | TIRQCSATGNTYTAV HHHHHCCCCCCEEEC | 18.05 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RFX3_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RFX3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RFX3_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TRAF2_HUMAN | TRAF2 | physical | 16189514 | |
RFX6_HUMAN | RFX6 | physical | 16189514 | |
TRIP6_HUMAN | TRIP6 | physical | 25416956 | |
SEC63_HUMAN | SEC63 | physical | 26186194 | |
PABP5_HUMAN | PABPC5 | physical | 26186194 | |
PABP5_HUMAN | PABPC5 | physical | 28514442 | |
MINY3_HUMAN | FAM188A | physical | 28514442 | |
IGSF8_HUMAN | IGSF8 | physical | 28514442 | |
HDAC1_HUMAN | HDAC1 | physical | 27173435 | |
XYLT2_HUMAN | XYLT2 | physical | 27173435 | |
RTCB_HUMAN | RTCB | physical | 27173435 | |
MTA2_HUMAN | MTA2 | physical | 27173435 | |
PTOV1_HUMAN | PTOV1 | physical | 27173435 | |
DDX1_HUMAN | DDX1 | physical | 27173435 | |
BROMI_HUMAN | TBC1D32 | physical | 27173435 | |
VPS45_HUMAN | VPS45 | physical | 27173435 | |
TAF6L_HUMAN | TAF6L | physical | 27173435 | |
MBD2_HUMAN | MBD2 | physical | 27173435 | |
CDK20_HUMAN | CDK20 | physical | 27173435 | |
ACAD9_HUMAN | ACAD9 | physical | 27173435 | |
HDAC2_HUMAN | HDAC2 | physical | 27173435 | |
TMED4_HUMAN | TMED4 | physical | 27173435 | |
FOXJ1_HUMAN | FOXJ1 | physical | 27173435 | |
CFA20_HUMAN | CFAP20 | physical | 27173435 | |
PLK1_HUMAN | PLK1 | physical | 27173435 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...